Nevanlinna H - Search Results

1

The impact of coding germline variants on contralateral breast cancer risk and survival.

Morra A, Mavaddat N, Muranen TA, Ahearn TU, Allen J, Andrulis IL, Auvinen P, Becher H, Behrens S, Blomqvist C, Bojesen SE, Bolla MK, Brauch H, Camp NJ, Carvalho S, Castelao JE, Cessna MH, Chang-Claude J, Chenevix-Trench G; NBCS Collaborators; Czene K, Decker B, Dennis J, Dörk T, Dorling L, Dunning AM, Ekici AB, Eriksson M, Evans DG, Fasching PA, Figueroa JD, Flyger H, Gago-Dominguez M, García-Closas M, Geurts-Giele WRR, Giles GG, Guénel P, Gündert M, Hahnen E, Hall P, Hamann U, Harrington PA, He W, Heikkilä P, Hooning MJ, Hoppe R, Howell A, Humphreys K; kConFab Investigators; Jakubowska A, Jung AY, Keeman R, Kristensen VN, Lubiński J, Mannermaa A, Manoochehri M, Manoukian S, Margolin S, Mavroudis D, Milne RL, Mulligan AM, Newman WG, Park-Simon TW, Peterlongo P, Pharoah PDP, Rhenius V, Saloustros E, Sawyer EJ, Schmutzler RK, Shah M, Spurdle AB, Tomlinson I, Truong T, van Veen EM, Vreeswijk MPG, Wang Q, Wendt C, Yang XR, Nevanlinna H, Devilee P, Easton DF, Schmidt MK. Morra A, et al. Among authors: nevanlinna h. Am J Hum Genet. 2023 Mar 2;110(3):475-486. doi: 10.1016/j.ajhg.2023.02.003. Epub 2023 Feb 23. Am J Hum Genet. 2023. PMID: 36827971 Free PMC article.

2

A low proportion of BRCA2 mutations in Finnish breast cancer families.

Vehmanen P, Friedman LS, Eerola H, Sarantaus L, Pyrhönen S, Ponder BA, Muhonen T, Nevanlinna H. Vehmanen P, et al. Among authors: nevanlinna h. Am J Hum Genet. 1997 May;60(5):1050-8. Am J Hum Genet. 1997. PMID: 9150152 Free PMC article.

3

Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes.

Vehmanen P, Friedman LS, Eerola H, McClure M, Ward B, Sarantaus L, Kainu T, Syrjäkoski K, Pyrhönen S, Kallioniemi OP, Muhonen T, Luce M, Frank TS, Nevanlinna H. Vehmanen P, et al. Among authors: nevanlinna h. Hum Mol Genet. 1997 Dec;6(13):2309-15. doi: 10.1093/hmg/6.13.2309. Hum Mol Genet. 1997. PMID: 9361038

4

Breast cancer risk estimation in families with history of breast cancer.

Muhonen T, Eerola H, Vehmanen P, Nevanlinna H, Aktan K, Blomqvist C, Kääriäinen H, Pyrhönen S. Muhonen T, et al. Among authors: nevanlinna h. Br J Cancer. 1997;76(9):1228-31. doi: 10.1038/bjc.1997.538. Br J Cancer. 1997. PMID: 9365174 Free PMC article.

5

Cancer risks in BRCA2 mutation carriers.

Breast Cancer Linkage Consortium. Breast Cancer Linkage Consortium. J Natl Cancer Inst. 1999 Aug 4;91(15):1310-6. doi: 10.1093/jnci/91.15.1310. J Natl Cancer Inst. 1999. PMID: 10433620

6

Familial breast cancer in southern Finland: how prevalent are breast cancer families and can we trust the family history reported by patients?

Eerola H, Blomqvist C, Pukkala E, Pyrhönen S, Nevanlinna H. Eerola H, et al. Among authors: nevanlinna h. Eur J Cancer. 2000 Jun;36(9):1143-8. doi: 10.1016/s0959-8049(00)00093-9. Eur J Cancer. 2000. PMID: 10854948

7

Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland.

Sarantaus L, Huusko P, Eerola H, Launonen V, Vehmanen P, Rapakko K, Gillanders E, Syrjäkoski K, Kainu T, Vahteristo P, Krahe R, Pääkkönen K, Hartikainen J, Blomqvist C, Löppönen T, Holli K, Ryynänen M, Bützow R, Borg A, Wasteson Arver B, Holmberg E, Mannermaa A, Kere J, Kallioniemi OP, Winqvist R, Nevanlinna H. Sarantaus L, et al. Among authors: nevanlinna h. Eur J Hum Genet. 2000 Oct;8(10):757-63. doi: 10.1038/sj.ejhg.5200529. Eur J Hum Genet. 2000. PMID: 11039575

8

A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families.

Vahteristo P, Eerola H, Tamminen A, Blomqvist C, Nevanlinna H. Vahteristo P, et al. Among authors: nevanlinna h. Br J Cancer. 2001 Mar 2;84(5):704-8. doi: 10.1054/bjoc.2000.1626. Br J Cancer. 2001. PMID: 11237395 Free PMC article.

9

Survival of breast cancer patients in BRCA1, BRCA2, and non-BRCA1/2 breast cancer families: a relative survival analysis from Finland.

Eerola H, Vahteristo P, Sarantaus L, Kyyrönen P, Pyrhönen S, Blomqvist C, Pukkala E, Nevanlinna H, Sankila R. Eerola H, et al. Among authors: nevanlinna h. Int J Cancer. 2001 Aug 1;93(3):368-72. doi: 10.1002/ijc.1341. Int J Cancer. 2001. PMID: 11433401

10

Risk of cancer in BRCA1 and BRCA2 mutation-positive and -negative breast cancer families (Finland).

Eerola H, Pukkala E, Pyrhönen S, Blomqvist C, Sankila R, Nevanlinna H. Eerola H, et al. Among authors: nevanlinna h. Cancer Causes Control. 2001 Oct;12(8):739-46. doi: 10.1023/a:1011272919982. Cancer Causes Control. 2001. PMID: 11562114

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

510 results

Search Page

Filters